$IMMR

Eric Singer Discloses Investment at Immersion Corporation with 5.5% Stake

Eric Singer, CEO of Immersion Corporation (IMMR), disclosed a 5.5% stake in the company's common stock via a Schedule 13D filing. The stake includes open-market purchases and stock awards. Singer may buy or sell shares, including under a 10b5-1 plan, but has no specific plans for major corporate actions. He is known for an activist approach in small- and mid-cap tech companies.

Original reporting
Published Aug 21, 2026, 11:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 22, 2026, 2:33 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Eric Singer Discloses Investment at Immersion Corporation with 5.5% Stake — source image
Decision brief

The 30-second read

$IMMRBullishMed
01

Why it matters

The 13D filing provides the first public disclosure of the CEO's sizable equity stake, offering a fresh data point for valuation models.

02

Market read

Insider ownership changes are closely watched by traders; this filing may prompt short‑term buying pressure.

03

What to watch

No disclosed plans for capital raises or major acquisitions that could dilute ownership.

Relevance 6/10Novelty 6/10Timing: filed Aug 21 2026

Background

Immersion Corporation develops haptic feedback technology for consumer electronics and gaming.

Company-level read

Ticker impact

$IMMRBullishHigh confidence
Context

CEO Eric Singer filed a Schedule 13D disclosing a 5.5% beneficial ownership stake in Immersion Corporation.

Expected impact

Potential modest upside as the market digests the insider stake increase.

Evidence & confidence

A 13D filing by the CEO is a primary source and material for investors; the size of the stake (5.5%) is significant for a mid‑cap tech firm.

Market effects

May highlight increased executive confidence in the haptic‑technology sector.

U.S. tech market perception could be modestly lifted.

Limited to investors tracking Immersion and related haptic technology firms.

Counterpoint

Stake increase could be a defensive move ahead of potential downside.

Key entities

  • Eric Singer

    President, CEO, and Chairman of Immersion Corporation.

  • Immersion Corporation

    Provider of haptic technology solutions.

Related articles

$IMMRHigh

Immersion Corporation Reports First Quarter of Fiscal 2027 Results

IMMERSION CORP (IMMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Immersion Corporation Reports First Quarter of Fiscal 2027 Results GAAP Net Income Attributable to Immersion Stockholders of $4.9 million or $0.17 per diluted share Non-GAAP Net Income Attributable to Immersion Stockholders of $16.6 million or $0.50 per diluted share

$IMMRMed

Immersion Corporation Reports Fourth Quarter and Fiscal 2026 Results

IMMERSION CORP (IMMR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 immr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Immersion Corporation Reports Fourth Quarter and Fiscal 2026 Results Fourth Quarter GAAP Net Income Attributable to Immersion Stockholders of $3.7 million or $0.12 per diluted share Fourth Quarter Non-GAAP Net Income Attribut

$SFLMedAI 8/10

Newbuild order for two very large ammonia acriers in combination with long term time charters

SFL Corporation ordered two 93,000 cbm ammonia carriers for $216 million, deliverable in 2028. The company also secured long-term charters with an oil major, adding $162 million to its backlog. CEO Ole B. Hjertaker highlighted the investment's accretive nature and the charterer's investment-grade status. The total fixed-rate charter backlog for 2026 exceeds $1.3 billion.

$CVXLow

Chevron announces senior leadership changes

Chevron (CVX) announced senior leadership changes effective January 1, 2027. Mark Nelson will focus on strategy and business development, Eimear Bonner will lead Oil, Products & Gas, Jeff Gustavson will become CFO, and Brent Gros will head New Energies and AI strategy. CEO Mike Wirth praised the new leaders' expertise and commitment.

$RAREHighAI 9/10

Ultragenyx agrees to sell voucher for US$210M

Ultragenyx Pharmaceutical (NASDAQ: RARE) agreed to sell a rare pediatric disease priority review voucher for $210M, nearly half its cash reserves. The deal, subject to regulatory approval, follows the FDA's August approval of its Genglycos gene therapy. Shares rose 2.97% on the news. Ultragenyx plans to use proceeds to advance rare disease therapies and support profitability. The price is within the range of recent voucher transactions, such as Rocket Pharmaceuticals' $180M deal.